# Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)

> **NCT05207475** · NA · UNKNOWN · sponsor: **Capital Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Cerebral Amyloid Angiopathy

## Interventions

- **DEVICE:** Remote ischemic conditioning

## Key facts

- **NCT ID:** NCT05207475
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-20
- **Primary completion:** 2022-01-20
- **Final completion:** 2022-01-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05207475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05207475, "Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05207475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*